DMSFX Mutual Fund

NAV$10.36

Fund Essentials - as of Nov 30, 2025

Net Assets
$528M
Expense Ratio
1.32%
Dividend Yield (Current)
3.51%
Holdings
144
Inception Date
Mar 20, 2017
Fund Family
Destinations Funds
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Quarterly

Performance

YTD+0.63%
1 Year+3.63%
3 Year+4.91%
5 Year+3.68%

Asset Allocation

Stocks: 22.76%
Bonds: 58.37%
Cash: 0.37%
Other: 18.50%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
APPApplovin Corp., Class 'A'13.26%
-Barings Clo Ltd 2021-I Ser 2021-1A Cl B V/R Regd 144A P/P 7.039830002.46%
XENEXenon Pharmaceuticals Inc2.03%
VST V7 PERP 144AVistra Corp Regd V/R /Perp/ 144A P/P 7.000000001.99%
CRNXCrinetics Pharmaceuticals In1.72%
Top 10 Concentration: 29.02%Report Date: Nov 30, 2025
Download all 144 holdings for DMSFX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
3.51%
Frequency
Quarterly
Latest Distribution
$0.17
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how DMSFX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

DMSFX Mutual Fund Overview

DMSFX Mutual Fund (Destinations Multi Strategy Alternatives Fund Class I) is managed by Destinations Funds with $528.1M in net assets. DMSFX expense ratio is 1.32%, holding 144 positions across sectors including Other, Unknown, Financials. Inception date: 2017-03-20.

DMSFX performance shows a YTD return of 0.63%. The 1-year return is 3.63% and the 5-year return is 3.68%. DMSFX dividend yield stands at 3.51%, paid quarterly.

DMSFX top holdings include Applovin Corp., Class 'A' (13.3%), Barings Clo Ltd 2021-I Ser 2021-1A Cl B V/R Regd 144A P/P 7.03983000 (2.5%), Xenon Pharmaceuticals Inc (2.0%), Vistra Corp Regd V/R /Perp/ 144A P/P 7.00000000 (2.0%), Crinetics Pharmaceuticals In (1.7%). View all DMSFX holdings, sector breakdown, or dividend history.

DMSFX can be compared against other funds using the overlap calculator or side-by-side comparison tool. DMSFX alternatives are available via the screener, along with tax-loss harvesting opportunities.